Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GSK-3 signaling in health
James A. McCubrey, Lucio Cocco
Advances in Biological Regulation (2017) Vol. 65, pp. 1-4
Closed Access | Times Cited: 10

Showing 10 citing articles:

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
Takahiro Domoto, Masahiro Uehara, Dilireba Bolidong, et al.
Cells (2020) Vol. 9, Iss. 6, pp. 1388-1388
Open Access | Times Cited: 87
Metformin influences drug sensitivity in pancreatic cancer cells
Saverio Candido, Stephen L. Abrams, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 68, pp. 13-30
Closed Access | Times Cited: 48
Abilities of berberine and chemically modified berberines to inhibit proliferation of pancreatic cancer cells
Stephen L. Abrams, Matilde Y. Follo, Linda S. Steelman, et al.
Advances in Biological Regulation (2018) Vol. 71, pp. 172-182
Closed Access | Times Cited: 42
Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals
Stephen L. Abrams, Kvin Lertpiriyapong, Li V. Yang, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 16-34
Closed Access | Times Cited: 35
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells—Power of nutraceuticals
James A. McCubrey, Stephen L. Abrams, Kvin Lertpiriyapong, et al.
Advances in Biological Regulation (2017) Vol. 67, pp. 190-211
Closed Access | Times Cited: 28
Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
William H. Chappell, Saverio Candido, Stephen L. Abrams, et al.
Advances in Biological Regulation (2018) Vol. 69, pp. 43-62
Closed Access | Times Cited: 21
Glycogen synthase kinase 3β: the nexus of chemoresistance, invasive capacity, and cancer stemness in pancreatic cancer
Masahiro Uehara, Takahiro Domoto, Satoshi Takenaka, et al.
Cancer Drug Resistance (2024)
Open Access | Times Cited: 1
Glycogen synthase kinase-3 beta inhibitors protectagainst the acute lung injuries resulting from acute necrotizing pancreatitis
Hongzhong Jin, Xiaojia Yang, Kailiang Zhao, et al.
Acta Cirúrgica Brasileira (2019) Vol. 34, Iss. 6
Open Access | Times Cited: 11
Development of a Clathrate Complex of 3-(2-Phenylethyl)-2-Thioxo-1,3-Thiazolidin-4-one with β-Cyclodextrin and Studying its Antitumor Activity
Yu. E. Antipova, K. T. Erimbetov, O. V. Buyuklinskayа
Journal Biomed (2024) Vol. 20, Iss. 3E, pp. 14-19
Open Access
Design, Bio‐evaluation and Molecular Dynamics Simulation of Novel GSK‐3β Inhibitors
Weiping Lyu, Qihang Li, Qi Li, et al.
Molecular Informatics (2021) Vol. 40, Iss. 12
Closed Access | Times Cited: 2
Page 1

Scroll to top